Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial
2020 · Journal of Translational Medicine · 111 citations
https://doi.org/10.1186/s12967-020-02573-9
M
Matteo Giorgi‐Pierfranceschi
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
75
Papers
1.8K
Citations
24
h-index
35
i10-index
Matteo Giorgi‐Pierfranceschi is an academic researcher from Ospedale Santa Maria della Misericordia di Udine. The author has contributed to research in topics: Venous Thromboembolism Diagnosis and Management & Atrial Fibrillation Management and Outcomes & COVID-19 Clinical Research Studies. The author has an h-index of 24, co-authored 64 publications.
ORCID: 0000-0002-7988-9652Papers by this author
worksCanakinumab as treatment for COVID-19-related pneumonia: A prospective case-control study
2020 · International Journal of Infectious Diseases · 63 citations
https://doi.org/10.1016/j.ijid.2020.12.073
Clinical outcomes during anticoagulant therapy in fragile patients with venous thromboembolism
2017 · Research and Practice in Thrombosis and Haemostasis · 30 citations
https://doi.org/10.1002/rth2.12036
Identification of hemodynamically stable patients with acute pulmonary embolism at high risk for death: external validation of different models
2024 · Journal of Thrombosis and Haemostasis · 12 citations
https://doi.org/10.1016/j.jtha.2024.04.025
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat